4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
IDEAYA Biosciences, Inc. (IDYA) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 145 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, IDYA reported $219M in revenue and ($114M) in net income.
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
Interactive charts & full statements → Open the IDYA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $219M | $7M | $23M | $51M | — |
| Operating Income (EBIT) | ($159M) | ($327M) | ($134M) | ($62M) | — |
| Net Income | ($114M) | ($274M) | ($113M) | ($59M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $7M | $11M | $208M | $0M | $0M |
| Operating Income (EBIT) | ($108M) | ($95M) | $108M | ($89M) | ($84M) |
| Net Income | ($98M) | ($83M) | $119M | ($78M) | ($72M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.1B | $1.1B | $649M | $388M | — |
| Total Liabilities | $86M | $65M | $28M | $38M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IDYA viewer.
About TickerBase · Data methodology & sources